<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33855783</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43's mRNA splicing activity.</ArticleTitle><Pagination><StartPage>e51649</StartPage><MedlinePgn>e51649</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e51649</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.202051649</ELocationID><Abstract><AbstractText>Pathological TDP-43 aggregation is characteristic of several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP); however, how TDP-43 aggregation and function are regulated remain poorly understood. Here, we show that O-GlcNAc transferase OGT-mediated O-GlcNAcylation of TDP-43 suppresses ALS-associated proteinopathies and promotes TDP-43's splicing function. Biochemical and cell-based assays indicate that OGT's catalytic activity suppresses TDP-43 aggregation and hyperphosphorylation, whereas abolishment of TDP-43 O-GlcNAcylation impairs its RNA splicing activity. We further show that TDP-43 mutations in the O-GlcNAcylation sites improve locomotion defects of larvae and adult flies and extend adult life spans, following TDP-43 overexpression in Drosophila motor neurons. We finally demonstrate that O-GlcNAcylation of TDP-43 promotes proper splicing of many mRNAs, including STMN2, which is required for normal axonal outgrowth and regeneration. Our findings suggest that O-GlcNAcylation might be a target for the treatment of TDP-43-linked pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Meng-Jie</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0001-7245-8473</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, College of Life Sciences, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yao</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wei</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2742-719X</Identifier><AffiliationInfo><Affiliation>Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Clinical Research Institute, Affiliated Nanhua Hospital, University of South China, Hengyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Wen-Tian</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>Weili</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Xinxin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Lei-Lei</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Zhiyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Frontier Science Center for Immunology and Metabolism, Medical Research Institute at School of Medicine, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Wen-Jie</ForeName><Initials>WJ</Initials><Identifier Source="ORCID">0000-0001-5270-055X</Identifier><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Han-Ye</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Frontier Science Center for Immunology and Metabolism, Medical Research Institute at School of Medicine, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2102-9377</Identifier><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Ling</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7918-6682</Identifier><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Hong-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiwu</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9516-3384</Identifier><AffiliationInfo><Affiliation>Clinical Research Institute, Affiliated Nanhua Hospital, University of South China, Hengyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Hai-Ning</ForeName><Initials>HN</Initials><Identifier Source="ORCID">0000-0001-8062-5411</Identifier><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cell Homeostasis, RNA Institute, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2013CB910700</GrantID><Agency>Major State Basic Research Development Program of China</Agency><Country/></Grant><Grant><GrantID>31770843</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>32071135</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>31471010</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>31770833</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2020020601012225</GrantID><Agency>Application Fundamental Frontier Foundation of Wuhan</Agency><Country/></Grant><Grant><GrantID>19ZR1446400</GrantID><Agency>Natural Science Foundation of Shanghai</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">O-GlcNAcylation</Keyword><Keyword MajorTopicYN="N">RNA splicing</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>7</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33855783</ArticleId><ArticleId IdType="pmc">PMC8183420</ArticleId><ArticleId IdType="doi">10.15252/embr.202051649</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et al (2006) TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602&#x2013;611</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold CS, Johnson GV, Cole RN, Dong DL, Lee M, Hart GW (1996) The microtubule&#x2010;associated protein tau is extensively modified with O&#x2010;linked N&#x2010;acetylglucosamine. J Biol Chem 271: 28741&#x2013;28744</Citation><ArticleIdList><ArticleId IdType="pubmed">8910513</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling SC, Huelga SC, Lagier&#x2010;Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis&#x2010;Downes M, Platoshyn O, Parone PA et al (2013) ALS&#x2010;linked TDP&#x2010;43 mutations produce aberrant RNA splicing and adult&#x2010;onset motor neuron disease without aggregation or loss of nuclear TDP&#x2010;43. Proc Natl Acad Sci USA 110: E736&#x2013;E745</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S (2010) Cytoplasmic mislocalization of TDP&#x2010;43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci 30: 639&#x2013;649</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilen J, Bonini NM (2005) Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 39: 153&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pubmed">16285856</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP&#x2010;43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276: 36337&#x2013;36343</Citation><ArticleIdList><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE (2008) Multiple roles of TDP&#x2010;43 in gene expression, splicing regulation, and human disease. Front Biosci 13: 867&#x2013;878</Citation><ArticleIdList><ArticleId IdType="pubmed">17981595</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP&#x2010;43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20: 1774&#x2013;1784</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Che MX, Jiang YJ, Xie YY, Jiang LL, Hu HY (2011) Aggregation of the 35&#x2010;kDa fragment of TDP&#x2010;43 causes formation of cytoplasmic inclusions and alteration of RNA processing. FASEB J 25: 2344&#x2013;2353</Citation><ArticleIdList><ArticleId IdType="pubmed">21450909</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HJ, Topp SD, Hui HS, Zacco E, Katarya M, McLoughlin C, King A, Smith BN, Troakes C, Pastore A et al (2019) RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP&#x2010;43 proteinopathy. Brain 142: 3753&#x2013;3770</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6885686</ArticleId><ArticleId IdType="pubmed">31605140</ArticleId></ArticleIdList></Reference><Reference><Citation>Choksi DK, Roy B, Chatterjee S, Yusuff T, Bakhoum MF, Sengupta U, Ambegaokar S, Kayed R, Jackson GR (2014) TDP&#x2010;43 Phosphorylation by casein kinase Iepsilon promotes oligomerization and enhances toxicity in vivo. Hum Mol Genet 23: 1025&#x2013;1035</Citation><ArticleIdList><ArticleId IdType="pubmed">24105464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP&#x2010;43 function and aggregation propensity. Nat Commun 6: 5845</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Lee VM, Trojanowski JQ (2011) TDP&#x2010;43 functions and pathogenic mechanisms implicated in TDP&#x2010;43 proteinopathies. Trends Mol Med 17: 659&#x2013;667</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, Lanson NA Jr, Smith RB, Casci I, Maltare A, Monaghan J, Nichols CD, Kryndushkin D, Shewmaker F, Pandey UB (2013) RNA&#x2010;binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS&#x2010;linked mutations. Hum Mol Genet 22: 1193&#x2013;1205</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC (2011) Wild&#x2010;type and A315T mutant TDP&#x2010;43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 20: 2308&#x2013;2321</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Groth AC, Fish M, Nusse R, Calos MP (2004) Construction of transgenic Drosophila by using the site&#x2010;specific integrase from phage phiC31. Genetics 166: 1775&#x2013;1782</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1470814</ArticleId><ArticleId IdType="pubmed">15126397</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et al (2008) Phosphorylated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64: 60&#x2013;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss WD, Szelies B, Kessler J, Herholz K (1991) Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann N Y Acad Sci 640: 65&#x2013;71</Citation><ArticleIdList><ArticleId IdType="pubmed">1776760</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490: 115&#x2013;125</Citation><ArticleIdList><ArticleId IdType="pubmed">15094078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh YL, Su FY, Tsai LK, Huang CC, Ko YL, Su LW, Chen KY, Shih HM, Hu CM, Lee WH (2019) NPGPx&#x2010;mediated adaptation to oxidative stress protects motor neurons from degeneration in aging by directly modulating O&#x2010;GlcNAcase. Cell Rep 29: 2134&#x2013;2143 e2137</Citation><ArticleIdList><ArticleId IdType="pubmed">31747588</ArticleId></ArticleIdList></Reference><Reference><Citation>Igaz LM, Kwong LK, Lee EB, Chen&#x2010;Plotkin A, Swanson E, Unger T, Malunda J, Xu Y, Winton MJ, Trojanowski JQ et al (2011) Dysregulation of the ALS&#x2010;associated gene TDP&#x2010;43 leads to neuronal death and degeneration in mice. J Clin Invest 121: 726&#x2013;738</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3026736</ArticleId><ArticleId IdType="pubmed">21206091</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Katsuno M, Takagi S, Ishigaki S, Niwa J, Hasegawa M, Tanaka F, Sobue G (2012) Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP&#x2010;43 linked to TDP&#x2010;43 proteinopathies. Neurobiol Dis 45: 862&#x2013;870</Citation><ArticleIdList><ArticleId IdType="pubmed">22198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, McCaffery JM, Lindquist S, Gitler AD (2008) A yeast TDP&#x2010;43 proteinopathy model: Exploring the molecular determinants of TDP&#x2010;43 aggregation and cellular toxicity. Proc Natl Acad Sci USA 105: 6439&#x2013;6444</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, Rochefort D, Bel Hadj S, Durham HD, Vande Velde C et al (2010) Gain and loss of function of ALS&#x2010;related mutations of TARDBP (TDP&#x2010;43) cause motor deficits in vivo. Hum Mol Genet 19: 671&#x2013;683</Citation><ArticleIdList><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Khidekel N, Ficarro SB, Clark PM, Bryan MC, Swaney DL, Rexach JE, Sun YE, Coon JJ, Peters EC, Hsieh&#x2010;Wilson LC (2007) Probing the dynamics of O&#x2010;GlcNAc glycosylation in the brain using quantitative proteomics. Nat Chem Biol 3: 339&#x2013;348</Citation><ArticleIdList><ArticleId IdType="pubmed">17496889</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis&#x2010;Dusenbery BN, Mordes DA, Burberry A, Steinbaugh MJ, Gamage KK, Kirchner R et al (2019) ALS&#x2010;implicated protein TDP&#x2010;43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci 22: 167&#x2013;179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Lee VM, Trojanowski JQ (2011) Gains or losses: molecular mechanisms of TDP43&#x2010;mediated neurodegeneration. Nat Rev Neurosci 13: 38&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Lee TA, Lee E, Kang S, Park A, Kim SW, Park HJ, Yoon JH, Ha SJ, Park T et al (2015) Identification of a subnuclear body involved in sequence&#x2010;specific cytokine RNA processing. Nat Commun 6: 5791</Citation><ArticleIdList><ArticleId IdType="pubmed">25557830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre T, Ferreira S, Dupont&#x2010;Wallois L, Bussiere T, Dupire MJ, Delacourte A, Michalski JC, Caillet&#x2010;Boudin ML (2003) Evidence of a balance between phosphorylation and O&#x2010;GlcNAc glycosylation of Tau proteins&#x2013;a role in nuclear localization. Biochim Biophys Acta 1619: 167&#x2013;176</Citation><ArticleIdList><ArticleId IdType="pubmed">12527113</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, Woodruff EA 3rd, Fushimi K, Wu JY (2010) A Drosophila model for TDP&#x2010;43 proteinopathy. Proc Natl Acad Sci USA 107: 3169&#x2013;3174</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC (2013) CDC7 inhibition blocks pathological TDP&#x2010;43 phosphorylation and neurodegeneration. Ann Neurol 74: 39&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775949</ArticleId><ArticleId IdType="pubmed">23424178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin DM, Goodman CS (1994) Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13: 507&#x2013;523</Citation><ArticleIdList><ArticleId IdType="pubmed">7917288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Iqbal K, Grundke&#x2010;Iqbal I, Hart GW, Gong CX (2004) O&#x2010;GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101: 10804&#x2013;10809</Citation><ArticleIdList><ArticleId IdType="pmc">PMC490015</ArticleId><ArticleId IdType="pubmed">15249677</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Han G, Yin Y, Jiang S, Yu G, Yang Q, Yu W, Ye X, Su Y, Yang Y et al (2018) AANL (Agrocybe aegerita lectin 2) is a new facile tool to probe for O&#x2010;GlcNAcylation. Glycobiology 28: 363&#x2013;373</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454498</ArticleId><ArticleId IdType="pubmed">29562282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludemann N, Clement A, Hans VH, Leschik J, Behl C, Brandt R (2005) O&#x2010;glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J Biol Chem 280: 31648&#x2013;31658</Citation><ArticleIdList><ArticleId IdType="pubmed">16006557</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E, Lorenzini I, Barrameda D, O'Conner AG, Barrows JM, Starr A, Kovalik T, Rabichow BE, Lehmkuhl EM, Shreiner DD et al (2019) Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife 8: e45114</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, Lopez&#x2010;Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW et al (2019) Premature polyadenylation&#x2010;mediated loss of stathmin&#x2010;2 is a hallmark of TDP&#x2010;43&#x2010;dependent neurodegeneration. Nat Neurosci 22: 180&#x2013;190</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP&#x2010;43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell N, Zachara NE, Hart GW, Marth JD (2004) Ogt&#x2010;dependent X&#x2010;chromosome&#x2010;linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24: 1680&#x2013;1690</Citation><ArticleIdList><ArticleId IdType="pmc">PMC344186</ArticleId><ArticleId IdType="pubmed">14749383</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesiridis GS, Lee VM, Trojanowski JQ (2009) Mutations in TDP&#x2010;43 link glycine&#x2010;rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet 18: R156&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758707</ArticleId><ArticleId IdType="pubmed">19808791</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier&#x2010;Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C et al (2011) Long pre&#x2010;mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP&#x2010;43. Nat Neurosci 14: 459&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X, Vocadlo DJ, Krieger C (2012) Reduced protein O&#x2010;glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett 516: 296&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pubmed">22521585</ArticleId></ArticleIdList></Reference><Reference><Citation>Slawson C, Hart GW (2011) O&#x2010;GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer 11: 678&#x2013;684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3291174</ArticleId><ArticleId IdType="pubmed">21850036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E et al (2008) TDP&#x2010;43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V et al (2011) Characterizing the RNA targets and position&#x2010;dependent splicing regulation by TDP&#x2010;43. Nat Neurosci 14: 452&#x2013;458</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD (2011) The ALS&#x2010;associated proteins FUS and TDP&#x2010;43 function together to affect Drosophila locomotion and life span. J Clin Invest 121: 4118&#x2013;4126</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuzwa SA, Macauley MS, Heinonen JE, Shan X, Dennis RJ, He Y, Whitworth GE, Stubbs KA, McEachern EJ, Davies GJ et al (2008) A potent mechanism&#x2010;inspired O&#x2010;GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat Chem Biol 4: 483&#x2013;490</Citation><ArticleIdList><ArticleId IdType="pubmed">18587388</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ (2012) Increasing O&#x2010;GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol 8: 393&#x2013;399</Citation><ArticleIdList><ArticleId IdType="pubmed">22366723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuzwa SA, Vocadlo DJ (2014) O&#x2010;GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond. Chem Soc Rev 43: 6839&#x2013;6858</Citation><ArticleIdList><ArticleId IdType="pubmed">24759912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering&#x2010;Brown S, Dickson D, Petrucelli L (2007) Progranulin mediates caspase&#x2010;dependent cleavage of TAR DNA binding protein&#x2010;43. J Neurosci 27: 10530&#x2013;10534</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673167</ArticleId><ArticleId IdType="pubmed">17898224</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes&#x2010;Casey M, Ash P et al (2009) Aberrant cleavage of TDP&#x2010;43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci USA 106: 7607&#x2013;7612</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>